Package 73352-090-60

Brand: zanaflex

Generic: tizanidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 73352-090-60
Digits Only 7335209060
Product NDC 73352-090
Product ID 73352-090_4007fbf6-8eb7-85e9-e063-6394a90a4013
Description

60 CAPSULE in 1 BOTTLE (73352-090-60)

Marketing

Marketing Status
Marketed Since 2025-09-16
Brand zanaflex
Generic tizanidine hydrochloride
Sample Package No

Linked Drug Pages (1)

Zanaflex ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4007fbf6-8eb7-85e9-e063-6394a90a4013", "openfda": {"upc": ["0373352090600"], "unii": ["B53E3NMY5C"], "rxcui": ["2723708", "2723710"], "spl_set_id": ["9833a1b8-f530-4a06-bc77-7d11b6e94c65"], "manufacturer_name": ["Trifluent Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (73352-090-60)", "package_ndc": "73352-090-60", "marketing_start_date": "20250916"}], "brand_name": "Zanaflex", "product_id": "73352-090_4007fbf6-8eb7-85e9-e063-6394a90a4013", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "73352-090", "generic_name": "tizanidine hydrochloride", "labeler_name": "Trifluent Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zanaflex", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA213798", "marketing_category": "ANDA", "marketing_start_date": "20250916", "listing_expiration_date": "20261231"}